Literature DB >> 18602230

Inhibition of Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells by Phyllanthus urinaria extracts.

Chih-Ho Lai1, Shih-Hua Fang, Yerra Koteswara Rao, Madamanchi Geethangili, Chih-Hsin Tang, Ying-Ju Lin, Chien-Hui Hung, Wen-Ching Wang, Yew-Min Tzeng.   

Abstract

AIM OF THE STUDY: Helicobacter pylori is linked to a majority of peptic ulcers and to some types of gastric cancer, and its resistance to antibiotic treatment is now found worldwide. This study is aimed at evaluating the antimicrobial activity of Phyllanthus urinaria Linnea (Euphorbiaceae), chloroform (PUC) and methanol (PUM) extracts, and its eight isolates on H. pylori-infected human gastric epithelial AGS cells.
MATERIALS AND METHODS: The in vitro anti-bacterial activity of P. urinaria chloroform (PUC) and methanol (PUM) extracts, and its eight isolates were determined. Additional experiments were also performed to know the PUC and PUM ability to inhibit the H. pylori adhesion to and invasion of AGS cells, in addition to the effect of PUC on NF-kappaB activity as well as IL-8 synthesis during H. pylori infection of AGS cells.
RESULTS: The results revealed that crude extracts PUC and PUM showed potent antimicrobial activity against H. pylori than pure isolates. On the other hand, in vitroH. pylori-infection model revealed that the inhibition of bacterial adhesion and invasion to AGS cells has dramatically reduced by treatment of extract PUC, while PUM has the same moderate effect. Furthermore, H. pylori-induced nuclear factor (NF)-kappaB activation, and the subsequent release of interleukin (IL)-8 in AGS cells were also inhibited by the extract PUC.
CONCLUSIONS: These results open the possibility of considering P. urinaria a chemopreventive agent for peptic ulcer or gastric cancer, but this bioactivity should be confirmed in vivo in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602230     DOI: 10.1016/j.jep.2008.05.022

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

Review 1.  Overview of the phytomedicine approaches against Helicobacter pylori.

Authors:  Filipa F Vale; Mónica Oleastro
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 2.  An overview of important ethnomedicinal herbs of Phyllanthus species: present status and future prospects.

Authors:  Bharti Sarin; Nidhi Verma; Juan Pedro Martín; Aparajita Mohanty
Journal:  ScientificWorldJournal       Date:  2014-02-03

3.  Bioguided Fraction and Isolation of the Antitumor Components from Phyllanthus niruri L.

Authors:  Zhi-Zhong Zheng; Liang-Hua Chen; Shao-Song Liu; Yuan Deng; Guo-Hua Zheng; Yue Gu; Yan-Lin Ming
Journal:  Biomed Res Int       Date:  2016-09-29       Impact factor: 3.411

4.  Purification of Cucurbitacins D, E, and I from Ecballium Elaterium (L.) A. Rich Fruits and Study of Their Cytotoxic Effects on the AGS Cell Line

Authors:  Naser Jafargholizadeh; Seyed Jalal Zargar; Narguess Yassa; Saeed Tavakoli
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

5.  A Review of the Phytochemistry and Pharmacology of Phyllanthus urinaria L.

Authors:  Madamanchi Geethangili; Shih-Torng Ding
Journal:  Front Pharmacol       Date:  2018-10-01       Impact factor: 5.810

6.  Phyllanthus amarus shoot cultures as a source of biologically active lignans: the influence of selected plant growth regulators.

Authors:  Barbara Sparzak-Stefanowska; Mirosława Krauze-Baranowska
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

7.  Evaluation of medicinal plants from Central Kalimantan for antimelanogenesis.

Authors:  Enos Tangke Arung; Irawan Wijaya Kusuma; Eva Oktoberiani Christy; Kuniyoshi Shimizu; Ryuichiro Kondo
Journal:  J Nat Med       Date:  2009-07-18       Impact factor: 3.192

8.  Excoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles.

Authors:  Hua-Yew Cheng; Chien-Min Yang; Ta-Chen Lin; Liang-Tzung Lin; Lien-Chai Chiang; Chun-Ching Lin
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-26       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.